Literature DB >> 10841172

Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues.

P H Watson1, L J Fraher, G N Hendy, U I Chung, M Kisiel, B V Natale, A B Hodsman.   

Abstract

The localization of PTH/PTH-related peptide (PTHrP) receptor (PTHR) has traditionally been performed by autoradiography. Specific polyclonal antibodies to peptides unique to the PTHR are now available, which allow a more precise localization of the receptor in cells and tissues. We optimized the IHC procedure for the rat PTHR using 5-microm sections of paraffin-embedded rat kidney, liver, small intestine, uterus, and ovary. Adjacent sections were analyzed for the presence of PTHR mRNA (by in situ hybridization) and PTHrP peptide. A typical pattern of staining for both receptor protein and mRNA was observed in kidney in cells lining the proximal tubules and collecting ducts. In uterus and gut, the receptor and its mRNA are present in smooth muscle layers (PTHrP target) and in glandular cuboidal cells and surface columnar epithelium. This suggests that PTH, or more likely PTHrP, plays a role in surface/secretory epithelia that is as yet undefined. In the ovary, PTHR was readily detectable in the thecal layer of large antral follicles and oocytes, and was present in the cytoplasm and/or nucleus of granulosa cells, regions that also contained receptor transcripts. PTHR protein and mRNA were found in the liver in large hepatocytes radiating outward from central veins. Immunoreactive cells were also present around the periphery of the liver but not within two or three cell layers of the surface. Clear nuclear localization of the receptor protein was present in liver cells in addition to the expected cytoplasmic/peripheral staining. PTHR immunoreactivity was present in the nucleus of some cells in every tissue examined. RT-PCR confirmed the presence of PTHR transcripts in these same tissues. Examination of the hindlimbs of PTHR gene-ablated mice showed no reaction to this antibody, whereas hindlimbs from their wild-type littermates stained positively. The results emphasize that the PTHR is highly expressed in diverse tissues and, in addition, show that the receptor protein itself can be localized to the cell nucleus. Nuclear localization of the receptor suggests that there is a role for PTH and/or PTHrP in the regulation of nuclear events, either on the physical environment (nucleoskeleton) or directly on gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841172     DOI: 10.1359/jbmr.2000.15.6.1033

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.

Authors:  Chad M Novince; Megan N Michalski; Amy J Koh; Benjamin P Sinder; Payam Entezami; Matthew R Eber; Glenda J Pettway; Thomas J Rosol; Thomas J Wronski; Ken M Kozloff; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines.

Authors:  Xiaoli Shen; Ramanjaneya V R Mula; B Mark Evers; Miriam Falzon
Journal:  Regul Pept       Date:  2007-01-10

Review 3.  G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function.

Authors:  Artavazd Tadevosyan; George Vaniotis; Bruce G Allen; Terence E Hébert; Stanley Nattel
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

4.  Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.

Authors:  P W M Ho; A Goradia; M R Russell; A M Chalk; K M Milley; E K Baker; J A Danks; J L Slavin; M Walia; B Crimeen-Irwin; R A Dickins; T J Martin; C R Walkley
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

Review 5.  Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets.

Authors:  T L Clemens; S Cormier; A Eichinger; K Endlich; N Fiaschi-Taesch; E Fischer; P A Friedman; A C Karaplis; T Massfelder; J Rossert; K D Schlüter; C Silve; A F Stewart; K Takane; J J Helwig
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

6.  Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease.

Authors:  Chengxiao Fu; Qi Pei; Wu Liang; Bo Yang; Wei Li; Jun Liu; Hongyi Tan; Chengxian Guo; Hao Zhang; Guoping Yang
Journal:  Drug Des Devel Ther       Date:  2022-07-13       Impact factor: 4.319

7.  The human gonadotropin releasing hormone type I receptor is a functional intracellular GPCR expressed on the nuclear membrane.

Authors:  Michelle Re; Macarena Pampillo; Martin Savard; Céléna Dubuc; Craig A McArdle; Robert P Millar; P Michael Conn; Fernand Gobeil; Moshmi Bhattacharya; Andy V Babwah
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

8.  Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein.

Authors:  Dengshun Miao; Hanyi Su; Bin He; Jianjun Gao; Qingwen Xia; Min Zhu; Zhen Gu; David Goltzman; Andrew C Karaplis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-17       Impact factor: 11.205

9.  Functional characterization of the parathyroid hormone 1 receptor in human periodontal ligament cells.

Authors:  Nuersailike Abuduwali; Stefan Lossdörfer; Jochen Winter; Dominik Kraus; Stefan Guhlke; Michael Wolf; Andreas Jäger
Journal:  Clin Oral Investig       Date:  2013-04-19       Impact factor: 3.573

Review 10.  The multifaceted actions of PTHrP in skeletal metastasis.

Authors:  Fabiana N Soki; Serk In Park; Laurie K McCauley
Journal:  Future Oncol       Date:  2012-07       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.